THE WOODLANDS, Texas, Nov. 13, 2024 (GLOBE NEWSWIRE) -- (NYSE: HHH) announced today it will host its 2024 Investor Day on Monday, November 18 in Summerlin®, the company’s award-winning master planned ...
Replimune Group (REPL – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Robert ...
In a report released today, Peter Lawson from Barclays maintained a Buy rating on Replimune Group (REPL – Research Report), with a price target of $17.00. The company’s shares closed yesterday at ...